Trial Profile
Effect of Tadalafil treatment in patients with benign prostatic hyperplasia with lower urinary tract symptoms after switched from Dutasteride
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2018
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary) ; Dutasteride
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms D-to-T trial
- 13 Feb 2018 New trial record